3 March 2026
Latham Advises Quadria Capital-Led Consortium on Take-Private of Apex Healthcare
Advising firms
Deal team
5 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Marcus Lee Lead | Latham & Watkins LLP | Partner | Not stated | Singapore |
| Elena Yeung | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Cher Lin Chin | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Chuan Wei Kong | Latham & Watkins LLP | Partner | finance | Singapore |
| Stephanie Adams | Latham & Watkins LLP | Partner | antitrust | London |
2 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 470m (US$470 million)
- What the figure measures
- Enterprise value
- Client
- Quadria CapitalBuy-side
- Counterparties
- Apex Healthcare Berhad (Target)